Bragar Eagel & Squire, P.C. Is Investigating Relmada, Bowlero, and Integra and Encourages Investors to Contact the Firm
June 04, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Relmada Therapeutics, Inc....
Bragar Eagel & Squire, P.C. Is Investigating Integra, and Chinook and Encourages Investors to Contact the Firm
May 30, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Integra LifeSciences...
Kaplan Fox Investigates Integra LifeSciences Holdings Corporation (NASDAQ: IART)
May 23, 2023 17:31 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors who purchased Integra LifeSciences Holdings...
Integra LifeSciences Opens New Center of Innovation and Learning
May 11, 2023 16:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, hosted a ribbon-cutting ceremony on Thursday,...
Integra LifeSciences Completes the Acquisition of Surgical Innovation Associates
December 06, 2022 17:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed...
Integra LifeSciences Announces Definitive Agreement to Acquire Surgical Innovation Associates (SIA) and Plans for $150 Million Share Repurchase
December 01, 2022 08:00 ET
|
Integra LifeSciences Holdings Corporation
Acquisition will add distinct new product solution for plastic and reconstructive surgery to address clinical needs and improve patient outcomes Deploys capital to support strong profitable growth...
Integra LifeSciences Announces Key Executive Appointment
October 06, 2022 16:10 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today announced the appointment of Harvinder Singh as executive vice president and...
Integra LifeSciences Publishes Its Inaugural ESG Report
September 29, 2022 08:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today issued its inaugural Environmental,...
Global Wound Closure Device Market is estimated to be US$ 26.93 billion by 2030 with a CAGR of 6.10% during the forecast period - By PMI
January 24, 2022 11:07 ET
|
PMI
Covina, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Global Wound Closure Device Market accounted for US$ 14.96 billion in 2020 and is estimated to be US$ 26.93 billion by 2030 and is anticipated to register...
Integra LifeSciences Announces Jan De Witte as President and Chief Executive Officer
October 28, 2021 08:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has appointed Jan D....